Santo J. Costa

Santo "Sandy" Costa has served as a member of our board of directors since November 2010. Mr Costa has over 35 years of experience within the pharmaceutical, biotechnology and related industries. Since 2007, Mr. Costa has been Of Counsel with Smith, Anderson, Blount, Dorsett, Mitchell and Jernigan, L.L.P., of Raleigh, North Carolina specializing in corporate law for healthcare companies. Prior to that, he was Of Counsel at the law firm of Maupin, Taylor & Ellis (now Williams Mullen), also of Raleigh, North Carolina. Previously, Mr. Costa held the role Vice Chairman and before that President and Chief Operating Officer of Quintiles Transnational Corporation. Prior to joining Quintiles, Mr. Costa spent 23 years in the pharmaceutical industry, most recently as General Counsel and Senior Vice-President Administration with Glaxo Inc., US Area Counsel with Merrell Dow Pharmaceuticals and Food & Drug Counsel with Norwich Eaton Pharmaceuticals. Mr. Costa currently serves as Chairman of LaboPharm. In the past, he served as Chairman of NeuroMedix and as a Director of CV Therapeutics, OSI Pharmaceuticals, NPS Pharmaceuticals, as well as, other public and private companies. Mr. Costa is an Adjunct Professor in the clinical research program at the Campbell University School of Pharmacy and also sits on the Board of Advisors of the Duke Cancer Patient Support Program Advisory Board, the Duke University Medical Center Board of Visitors, and the Duke Brain Tumor Advisory Board. Mr. Costa earned both his B.S. in Pharmacy and J.D from St. John's University.